Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, who has responsibility for preventing the availability of products containing Melanotan II in England; and what steps he has taken to tackle the availability of these products.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis taking into account the definition of a medicine in The Human Medicines Regulations 2012, relevant case law, and any other evidence.

Melanotan II injections and pens are considered medicinal products due to their similarity to an authorised medicinal product and potential application to other medical conditions.

However, tan-enhancing nasal products which are clearly marketed for self-tanning purposes and which do not have a medical purpose do not fall under medicines regulations and are not within the MHRA’s remit.

Medicinal products must hold a relevant Marketing Authorisation to be legally sold and supplied in the United Kingdom. This also guarantees that the medicines have been tested for conformity with strict standards of quality, safety, and efficacy.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, to set out the legal status of products containing Melanotan II, including i) tan-enhancing injections; ii) tan-enhancing nasal sprays; iii) other products the Department is aware of.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis, taking into account the definition of a medicine in the Human Medicines Regulations 2012, relevant case law, and any other evidence.

There are many products which modify physiological function but which are not medicinal products, and case law has established that products that do so while having no beneficial effects on human health cannot be medicines.

Melanotan II injections and pens are considered medicinal products due to their similarity to an authorised medicinal product and potential application to other medical conditions.

However, tan-enhancing nasal products which are clearly marketed for self-tanning purposes and which do not have a medical purpose do not fall under medicines regulations and are not within the MHRA’s remit.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the Cancer Plan will specifically address the availability of products containing Melanotan II.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is taking steps to prevent, diagnose, and treat cancers more quickly, including skin cancers. The forthcoming National Cancer Plan will cover the entirety of the cancer pathway from referral and diagnosis to treatment and ongoing care. It will set out how we will improve outcomes for cancer patients, including by speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates. We will publish the National Cancer Plan in the new year to reduce the number of lives lost to cancer over the next 10 years.

We received over 11,000 responses to our call for evidence from individuals, professionals, and organisations, and we are reviewing the submissions from skin cancer partners. While no formal assessment has been made of the availability and levels of the use of tan-enhancing products containing Melanotan II, respondents shared concerns about tanning products and their potential links to cancer, particularly melanoma. Our expansive engagement will allow the National Cancer Plan to have patients at its heart.

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicinal products and medical devices in the United Kingdom.

Although tanning is not considered to be a medical purpose, injectable products containing Melanotan I or Melanotan II have been determined as medicinal products due to their similarity to the authorised medicine Scenesse.

In relation to nasal sprays containing Melanotan I or Melanotan II, there are no equivalent authorised medicines, and in the absence of medicinal claims, they are not regarded as medicinal products.

Medicinal products must hold a relevant Marketing Authorisation to be legally sold and supplied in the United Kingdom. This also guarantees that the medicines have been tested for conformity with strict standards of quality, safety, and efficacy. The MHRA takes action when a medicinal product without appropriate authorisations is identified.

Question to the Home Office:

To ask the Secretary of State for the Home Department, which government departments and schemes will explicitly include families with No Recourse to Public Funds (NRPF) within their eligibility criteria following the introduction of new guidance; and what steps will be taken to monitor and enforce consistency of support across these schemes.

Answered by Mike Tapp - Parliamentary Under-Secretary (Home Office)

The new guidance being produced by the Home Office is designed to assist local authorities in supporting families with NRPF, as set out in the Child Poverty Strategy. The guidance will provide clarity around statutory duties and key safeguards for local authorities, ensuring a clear and consistent approach. The guidance does not alter the eligibility criteria for any current schemes or benefits.

Children whose families are subject to the ‘no recourse to public funds’ condition (NRPF) can currently access schemes and benefits such as free school meals, 15 hours of free childcare for disadvantaged two-year-olds and15 hours free childcare for three- to four-year-old.

The Home Office will continue to work across government where relevant to ensure that migrant children with NRPF are specifically considered when reviewing or deciding on eligibility for schemes and benefits.

Question to the Home Office:

To ask the Secretary of State for the Home Department, with reference to Restoring Control Over the Immigration System: White Paper, whether her Department plans to apply the 5 and 10 year penalties for accessing public funds to those on limited leave to remain who are currently living in the UK and receiving benefits.

Answered by Mike Tapp - Parliamentary Under-Secretary (Home Office)

Data regarding how many people in the UK are subject to the ‘no recourse to public funds’ condition (NRPF) is currently in development and not ready for release. We will continue to explore what further information on NRPF can be produced. We are unable at this time to provide a specific timeframe for data publication or indeed confirm what will be published.

The earned settlement model is currently subject to a public consultation, running until 12 February 2026. Details of the earned settlement scheme will be finalised following that consultation.

The consultation seeks views on whether there should be transitional arrangements for those already on a pathway to settlement. Consideration will then be given, if appropriate, to how transitional arrangements may be designed to ease the impact of policy change, especially for individuals or groups already afforded permissions by the previous system.

The final model will also be subject to equality impact assessment, which the government has committed to publish in due course.

Free school meals are not classed as a 'public fund' for immigration purposes. It is the Department for Education who set the eligibility criteria for who can access free school meals.

Question to the Home Office:

To ask the Secretary of State for the Home Department, how many (a) children and (b) adults are subject to the No Recourse to Public Funds condition.

Answered by Mike Tapp - Parliamentary Under-Secretary (Home Office)

Data regarding how many people in the UK are subject to the ‘no recourse to public funds’ condition (NRPF) is currently in development and not ready for release. We will continue to explore what further information on NRPF can be produced. We are unable at this time to provide a specific timeframe for data publication or indeed confirm what will be published.

The earned settlement model is currently subject to a public consultation, running until 12 February 2026. Details of the earned settlement scheme will be finalised following that consultation.

The consultation seeks views on whether there should be transitional arrangements for those already on a pathway to settlement. Consideration will then be given, if appropriate, to how transitional arrangements may be designed to ease the impact of policy change, especially for individuals or groups already afforded permissions by the previous system.

The final model will also be subject to equality impact assessment, which the government has committed to publish in due course.

Free school meals are not classed as a 'public fund' for immigration purposes. It is the Department for Education who set the eligibility criteria for who can access free school meals.

Question to the Ministry of Housing, Communities and Local Government:

To ask the Secretary of State for Housing, Communities and Local Government, what steps he is taking to ensure that the upcoming Homelessness Strategy addresses homelessness among newly recognised refugees arising from the 28 day move-on period.

Answered by Alison McGovern - Minister of State (Housing, Communities and Local Government)

Through A National Plan to End Homelessness, the Cross-Government Homelessness and Rough Sleeping Strategy, the Home Office has committed to strengthen data sharing processes to ensure councils receive information from asylum accommodation providers for 100% of newly granted refugees at risk of homelessness, within two days of an asylum discontinuation of support notification. This supports early intervention by enabling councils to commence homelessness assessments.

Buying community energy locally

Parliamentary screening of The Removed and historic forced adoptions

Cumulative disruption proposals and the right to protest

Right to trial by jury

Hunger strike by pro-Palestinian activists

Palestine Action hunger strike

Independent Office for Police Conduct findings on Norman Bettison

Thanking postal workers

Found: Current membership Mr Toby Perkins (Labour; Chesterfield) (Chair) Olivia Blake (Labour; Sheffield Hallam

Found: Current membership Mr Toby Perkins (Labour; Chesterfield) (Chair) Olivia Blake (Labour; Sheffield Hallam

Found: Watch the meeting Members present: Olivia Blake; Julia Buckley; Jonathan Davies; Carla Denyer; Barry

Found: Watch the meeting Members present: Olivia Blake; Julia Buckley; Jonathan Davies; Carla Denyer; Barry